Insider Trading History of Anicetti Vincent R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Anicetti Vincent R since 2019. This trader's CIK number is 1733375. At the time of last reporting, Anicetti Vincent R was the Chief Operating Officer of Coherus Biosciences, Inc.. (stock ticker symbol CHRS). Also see all insider trading activities at Coherus Biosciences, Inc..

Yearly summary of insider trading at Coherus Biosciences, Inc. (CHRS) by Anicetti Vincent R

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	CHRS	0	$0	31,637	$500,316	25,300	$201,375
2020	CHRS	0	$0	196,777	$3,657,579	165,047	$2,082,318
2019	CHRS	0	$0	15,000	$286,450	15,000	$37,512

Insider trading of Coherus Biosciences, Inc. (CHRS) by Anicetti Vincent R

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-03-05	CHRS	Option Ex	20,312	9.30	188,901
2021-03-05	CHRS	Sale	26,649	15.46	412,046
2021-02-17	CHRS	Option Ex	2,488	2.50	6,222
2021-02-17	CHRS	Sale	2,488	17.45	43,418
2021-01-19	CHRS	Sale	2,500	17.94	44,852
2021-01-19	CHRS	Option Ex	2,500	2.50	6,252
2020-12-17	CHRS	Option Ex	2,500	2.50	6,252
2020-12-17	CHRS	Sale	2,500	17.51	43,780
2020-12-07	CHRS	Option Ex	8,791	12.54	110,195
2020-12-07	CHRS	Sale	8,791	18.42	161,895
2020-12-04	CHRS	Sale	49,000	18.85	923,699
2020-12-03	CHRS	Sale	49,756	18.67	929,093
2020-12-04	CHRS	Option Ex	49,000	14.72	721,525
2020-12-03	CHRS	Option Ex	49,756	17.45	868,242
2020-11-17	CHRS	Option Ex	2,500	2.50	6,252
2020-11-18	CHRS	Option Ex	4,283	12.70	54,394
2020-11-17	CHRS	Sale	18,487	17.62	325,722
2020-11-18	CHRS	Sale	4,283	18.00	77,094
2020-10-19	CHRS	Sale	3,217	17.89	57,555
2020-10-19	CHRS	Option Ex	3,217	7.60	24,449
2020-09-17	CHRS	Option Ex	5,000	7.60	38,000
2020-09-17	CHRS	Sale	5,000	18.84	94,215
2020-08-17	CHRS	Option Ex	5,000	7.60	38,000
2020-08-17	CHRS	Sale	5,000	19.37	96,850
2020-07-17	CHRS	Option Ex	15,000	7.60	114,000
2020-07-17	CHRS	Sale	15,000	18.25	273,690
2020-06-17	CHRS	Option Ex	2,500	2.50	6,252
2020-06-17	CHRS	Sale	2,500	17.22	43,050
2020-05-18	CHRS	Option Ex	2,500	2.50	6,252
2020-05-18	CHRS	Sale	3,093	17.17	53,106
2020-04-17	CHRS	Option Ex	5,000	2.50	12,505
2020-04-20	CHRS	Sale	5,150	17.00	87,550
2020-04-17	CHRS	Sale	5,000	15.57	77,850
2020-02-18	CHRS	Option Ex	5,000	7.60	38,000
2020-02-18	CHRS	Sale	10,000	21.64	216,390
2020-01-17	CHRS	Sale	10,000	19.60	196,040
2020-01-17	CHRS	Option Ex	5,000	7.60	38,000
2019-12-16	CHRS	Option Ex	2,500	2.50	6,252
2019-12-16	CHRS	Sale	2,500	18.69	46,725
2019-11-14	CHRS	Sale	2,500	19.26	48,150
2019-11-14	CHRS	Option Ex	2,500	2.50	6,252
2019-10-14	CHRS	Sale	2,500	18.40	46,000
2019-10-14	CHRS	Option Ex	2,500	2.50	6,252
2019-09-16	CHRS	Sale	2,500	20.03	50,075
2019-09-16	CHRS	Option Ex	2,500	2.50	6,252
2019-08-14	CHRS	Option Ex	2,500	2.50	6,252
2019-08-14	CHRS	Sale	2,500	19.00	47,500
2019-07-15	CHRS	Option Ex	2,500	2.50	6,252
2019-07-15	CHRS	Sale	2,500	19.20	48,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anicetti Vincent R (Chief Operating Officer of Coherus Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month